Quarterly Earnings

Riot Platforms reports a record $647M revenue for 2025, but a staggering net loss and a strategic pivot to data centers raises critical questions.

Colombia's energy giant is set to reveal its 2025 performance, testing its diversification strategy against falling oil prices and high investor expectations.

After a major turnaround, Genetix Biotherapeutics announces its first profitable quarter and plans to double production of its high-stakes gene therapies.

Fresh off a major clinical trial victory, Alumis Inc. heads to a key investor conference. What's next for its promising pipeline and soaring stock?

With major trials underway for its cancer and vision drugs, NovaBridge's upcoming investor presentation could be a pivotal moment for the biotech firm.

HVAC giant AAON reports record 2025 sales but lower earnings due to massive investments. A $1.83B backlog signals a powerful 2026 rebound.

Nike's rescheduled Q3 earnings report on March 31 amplifies anxiety as the giant battles tariffs, a China slump, and deep market skepticism.

A class action lawsuit alleges hospital operator Ardent Health misled investors by hiding financial risks, leading to a 33% stock price collapse.

National CineMedia's revenue outpaced attendance in a strong Q4, but a full-year loss and weak 2026 forecast raise questions about its future strategy.

French marketing giant DEKUPLE reports stellar 2025 growth, driven by strategic acquisitions, AI integration, and a bold international expansion strategy.

Following a historic $2B revenue year, Tradeweb's CEO will address institutional investors, focusing on AI, digital assets, and global market expansion.

As CLPS prepares to release H1 FY2026 results, investors are watching for sustained recovery and the impact of its global diversification strategy.

Aragon Research names LivePerson a Leader as the market shifts from chatbots to sophisticated AI agents, highlighting its focus on trust and reliability.

A staggering loss at JinkoSolar's key subsidiary reveals a brutal price war and oversupply crisis rocking the global solar manufacturing sector.

The natural gas producer raised its quarterly dividend by 11%, backed by strong earnings and a positive outlook despite volatile energy prices.

The organ transplant innovator's massive Q4 profit came from a tax rule, but it signals a major turning point and confidence in long-term profitability.

Treace Medical reports a Q4 revenue dip despite surgeon growth, revealing a strategic shift to lower-priced kits and a challenging 2026 outlook.

As BCE's CEO prepares for a key investor conference, the telecom giant balances a bold AI growth strategy against concerns over near-term profitability.

Natural Resource Partners reports robust cash flow and near-zero debt, but severe headwinds in coal and soda ash markets test its long-term strategy.

The luxury marketplace achieved its first profitable quarter, a win for financial discipline. But with user metrics down, the focus now shifts to its 2026 growth plan.